Showing results (1941-1950 of 2,113) with videos related to
Sort By:
Pageof 212
Frontiers in Neurology|November 12, 2014
Chiari 1 Malformation Presenting as Central Sleep Apnea during Pregnancy: A Case Report, Treatment Considerations, and Review of the LiteratureErik K St Louis, Praveen Jinnur, Stuart J McCarter, et al.Annals of Surgery|May 9, 2012
Medical and financial risks associated with surgery in the elderly obeseJeffrey H Silber, Paul R Rosenbaum, Rachel R Kelz, et al.Genes|August 17, 2018
Proteome-Wide Analysis of Trypanosoma cruzi Exponential and Stationary Growth Phases Reveals a Subcellular Compartment-Specific RegulationCarla Cristi Avila, Simon Ngao Mule, Livia Rosa-Fernandes, et al.The American Journal of Emergency Medicine|February 5, 2020
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulantsCharles V Pollack, W Frank Peacock, Richard A Bernstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell TumorsDeaglan J McHugh, Samuel A Funt, Deborah Silber, et al.The New England Journal of Medicine|September 5, 2019
Trial of SAGE-217 in Patients with Major Depressive DisorderHandan Gunduz-Bruce, Christopher Silber, Inder Kaul, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclinesJeffrey H Silber, Avital Cnaan, Bernard J Clark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclinesJill P Ginsberg, Avital Cnaan, Huaqing Zhao, et al.Clinical and Vaccine Immunology : CVI|December 14, 2007
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of ZostavaxLarry I Gilderman, James F Lawless, Thomas M Nolen, et al.JAMA Network Open|August 29, 2020
Effect of Short-term Integrated Palliative Care on Patient-Reported Outcomes Among Patients Severely Affected With Long-term Neurological Conditions: A Randomized Clinical TrialWei Gao, Rebecca Wilson, Nilay Hepgul, et al.Pageof 212